Athanassios Argiris

  • 6355 Citations
  • 42 h-Index
1977 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2019

Laryngeal preservation strategies in locally advanced laryngeal and hypopharyngeal cancers

Argiris, A. & Lefebvre, J. L., Jan 1 2019, In : Frontiers in Oncology. 9, MAY, 419.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies

Appleman, L. J., Beumer, J. H., Jiang, Y., Lin, Y., Ding, F., Puhalla, S., Swartz, L., Owonikoko, T. K., Donald Harvey, R., Stoller, R., Petro, D. P., Tawbi, H. A., Argiris, A., Strychor, S., Pouquet, M., Kiesel, B., Chen, A. P., Gandara, D., Belani, C. P., Chu, E. & 1 others, Ramalingam, S. S., Dec 1 2019, In : Cancer chemotherapy and pharmacology. 84, 6, p. 1289-1301 13 p.

Research output: Contribution to journalArticle

2 Scopus citations

Phase III randomized trial of chemotherapy with or without bevacizumab in patients with recurrent or metastatic head and neck cancer

Argiris, A., Li, S., Savvides, P., Ohr, J. P., Gilbert, J., Levine, M. A., Chakravarti, A., Haigentz, M., Saba, N. F., Ikpeazu, C. V., Schneider, C. J., Pinto, H. A., Forastiere, A. A. & Burtness, B., Jan 1 2019, In : Journal of Clinical Oncology. 37, 34, p. 3266-3274 9 p.

Research output: Contribution to journalArticle

5 Scopus citations
2018

Nivolumab and ipilimumab in combination with radiotherapy in patients with locally advanced head and neck cancer

Johnson, J. M., Bar Ad, V., Lorber, E., Luginbuhl, A., Curry, J. M., Cognetti, D., Keith, S., Axelrod, R., Zinner, R., Rodeck, U., Harshyne, L. A. & Argiris, A., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii399

Research output: Contribution to journalArticle

Open Access

Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives

Bauman, J. E., Duvvuri, U., Thomas, S., Gooding, W. E., Clump, D. A., Karlovits, B., Wehbe, A., Miller, F. R., Kim, S., Sen, M., Heron, D. E., Grandis, J. R. & Argiris, A., Oct 1 2018, In : Cancer. 124, 19, p. 3881-3889 9 p.

Research output: Contribution to journalArticle

2 Scopus citations
2017

Increased PD-1+ and TIM-3+ TILs during cetuximab therapy inversely correlate with response in head and neck cancer patients

Jie, H. B., Srivastava, R. M., Argiris, A., Bauman, J. E., Kane, L. P. & Ferris, R. L., May 1 2017, In : Cancer immunology research. 5, 5, p. 408-416 9 p.

Research output: Contribution to journalArticle

28 Scopus citations

Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer

Tarhini, A. A., Rafique, I., Floros, T., Tran, P., Gooding, W. E., Villaruz, L. C., Burns, T. F., Friedland, D. M., Petro, D. P., Farooqui, M., Gomez-Garcia, J., Gaither-Davis, A., Dacic, S., Argiris, A., Socinski, M. A., Stabile, L. P. & Siegfried, J. M., 2017, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

16 Scopus citations

Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3508)

Argiris, A., Lee, J. W., Stevenson, J., Sulecki, M. G., Hugec, V., Choong, N. W., Saltzman, J. N., Song, W., Hansen, R. M., Evans, T. L., Ramalingam, S. S. & Schiller, J. H., Dec 1 2017, In : Annals of Oncology. 28, 12, p. 3037-3043 7 p.

Research output: Contribution to journalArticle

5 Scopus citations

Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non–Small Cell Lung Cancer

Ou, S. H. I., Govindan, R., Eaton, K. D., Otterson, G. A., Gutierrez, M. E., Mita, A. C., Argiris, A., Brega, N. M., Usari, T., Tan, W., Ho, S. N. & Robert, F., Jan 1 2017, In : Journal of Thoracic Oncology. 12, 1, p. 145-151 7 p.

Research output: Contribution to journalArticle

27 Scopus citations
2016

A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

Jimeno, A., Posner, M. R., Wirth, L. J., Saba, N. F., Cohen, R. B., Popa, E. C., Argiris, A., Grossmann, K. F., Sukari, A., Wilson, D., Zhang, X., Sun, J., Glasser, C., Attie, K. M., Sherman, M. L., Pandya, S. S. & Weiss, J., Dec 1 2016, In : Cancer. 122, 23, p. 3641-3649 9 p.

Research output: Contribution to journalArticle

14 Scopus citations
Open Access

Characterization of human papillomavirus antibodies in individuals with head and neck cancer

Lang Kuhs, K. A., Pawlita, M., Gibson, S. P., Schmitt, N. C., Trivedi, S., Argiris, A., Kreimer, A. R., Ferris, R. L. & Waterboer, T., Jun 1 2016, In : Cancer Epidemiology. 42, p. 46-52 7 p.

Research output: Contribution to journalArticle

15 Scopus citations

Emerging aspects of nanotoxicology in health and disease: From agriculture and food sector to cancer therapeutics

Piperigkou, Z., Karamanou, K., Engin, A. B., Gialeli, C., Docea, A. O., Vynios, D. H., Pavão, M. S. G., Golokhvast, K. S., Shtilman, M. I., Argiris, A., Shishatskaya, E. & Tsatsakis, A. M., May 1 2016, In : Food and Chemical Toxicology. 91, p. 42-57 16 p.

Research output: Contribution to journalArticle

64 Scopus citations

p53-Based strategy to reduce hematological toxicity of chemotherapy: A proof of principle study

Ha, C. S., Michalek, J. E., Elledge, R., Kelly, K. R., Ganapathy, S., Su, H., Jenkins, C. A., Argiris, A., Swords, R., Eng, T. Y., Karnad, A., Crownover, R. L., Swanson, G. P., Goros, M., Pollock, B. H. & Yuan, Z. M., Jan 1 2016, In : Molecular oncology. 10, 1, p. 148-156 9 p.

Research output: Contribution to journalArticle

7 Scopus citations

Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer

Argiris, A., Bauman, J. E., Ohr, J., Gooding, W. E., Heron, D. E., Duvvuri, U., Kubicek, G. J., Posluszny, D. M., Vassilakopoulou, M., Kim, S., Grandis, J. R., Johnson, J. T., Gibson, M. K., Clump, D. A., Flaherty, J. T., Chiosea, S. I., Branstetter, B. & Ferris, R. L., Aug 1 2016, In : Annals of Oncology. 27, 8, p. 1594-1600 7 p.

Research output: Contribution to journalArticle

13 Scopus citations

Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors

Wong, S. J., Karrison, T., Hayes, D. N., Kies, M. S., Cullen, K. J., Tanvetyanon, T., Argiris, A., Takebe, N., Lim, D., Saba, N. F., Worden, F. P., Gilbert, J., Lenz, H. J., Razak, A. R. A., Roberts, J. D., Vokes, E. E. & Cohen, E. E. W., Feb 1 2016, In : Annals of Oncology. 27, 2, p. 318-323 6 p., mdv537.

Research output: Contribution to journalArticle

27 Scopus citations

Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma

Geiger, J. L., Bauman, J. E., Gibson, M. K., Gooding, W. E., Varadarajan, P., Kotsakis, A., Martin, D., Gutkind, J. S., Hedberg, M. L., Grandis, J. R. & Argiris, A., Dec 1 2016, In : Head and Neck. 38, 12, p. 1759-1764 6 p.

Research output: Contribution to journalArticle

25 Scopus citations

Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer

Ferris, R. L., Geiger, J. L., Trivedi, S., Schmitt, N. C., Heron, D. E., Johnson, J. T., Kim, S., Duvvuri, U., Clump, D. A., Bauman, J. E., Ohr, J. P., Gooding, W. E. & Argiris, A., Dec 1 2016, In : Annals of oncology : official journal of the European Society for Medical Oncology. 27, 12, p. 2257-2262 6 p.

Research output: Contribution to journalArticle

10 Scopus citations

Postoperative treatment for head and neck cancer: The emerging role of EGFR-targeted therapy

Argiris, A. & Rapidis, A. D., Feb 1 2016, In : Translational Cancer Research. 5, 1, p. 17-19 3 p.

Research output: Contribution to journalArticle

2015

CTLA-4+ regulatory t cells increased in cetuximab-treated head and neck cancer patients suppress nk cell cytotoxicity and correlate with poor prognosis

Jie, H. B., Schuler, P. J., Lee, S. C., Srivastava, R. M., Argiris, A., Ferrone, S., Whiteside, T. L. & Ferris, R. L., Jun 1 2015, In : Cancer Research. 75, 11, p. 2200-2210 11 p.

Research output: Contribution to journalArticle

120 Scopus citations

EGFR inhibition for recurrent or metastatic HNSCC

Argiris, A., 2015, In : The Lancet Oncology. 16, 5, p. 488-489 2 p.

Research output: Contribution to journalArticle

12 Scopus citations

Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck

Yao, M., Galanopoulos, N., Lavertu, P., Fu, P., Gibson, M., Argiris, A., Rezaee, R., Zender, C., Wasman, J., Machtay, M. & Savvides, P., Nov 2015, In : Head and Neck. 37, 11, p. 1665-1671 7 p.

Research output: Contribution to journalArticle

22 Scopus citations

Posttraumatic stress disorder symptoms in newly diagnosed patients with head and neck cancer and their partners

Posluszny, D. M., Dougall, A. L., Johnson, J. T., Argiris, A., Ferris, R. L., Baum, A., Bovbjerg, D. H. & Dew, M. A., Sep 1 2015, In : Head and Neck. 37, 9, p. 1282-1289 8 p.

Research output: Contribution to journalArticle

26 Scopus citations

Targeting angiogenesis in head and neck cancer

Vassilakopoulou, M., Psyrri, A. & Argiris, A., 2015, In : Oral Oncology. 51, 5, p. 409-415 7 p.

Research output: Contribution to journalArticle

28 Scopus citations
2014

Erlotinib, erlotinib-sulindac versus placebo: A randomized, double-blind, placebo-controlled window trial in operable head and neck cancer

Gross, N. D., Bauman, J. E., Gooding, W. E., Denq, W., Thomas, S. M., Wang, L., Chiosea, S., Hood, B. L., Flint, M. S., Sun, M., Conrads, T. P., Ferris, R. L., Johnson, J. T., Kim, S., Argiris, A., Wirth, L., Nikiforova, M. N., Siegfried, J. M. & Grandis, J. R., Jun 15 2014, In : Clinical Cancer Research. 20, 12, p. 3289-3298 10 p.

Research output: Contribution to journalArticle

31 Scopus citations

Phase i dendritic cell p53 peptide vaccine for head and neck cancer

Schuler, P. J., Harasymczuk, M., Visus, C., De Leo, A., Trivedi, S., Lei, Y., Argiris, A., Gooding, W., Butterfield, L. H., Whiteside, T. L. & Ferris, R. L., May 1 2014, In : Clinical Cancer Research. 20, 9, p. 2433-2444 12 p.

Research output: Contribution to journalArticle

78 Scopus citations

Phase II study of cetuximab in combination with cisplatin and radiation in Unresectable, locally advanced head and neck squamous cell carcinoma: Eastern Cooperative Oncology Group Trial E3303

Marie Egloff, A., Lee, J. W., Langer, C. J., Quon, H., Vaezi, A., Grandis, J. R., Seethala, R. R., Wang, L., Shin, D. M., Argiris, A., Yang, D., Mehra, R., Andrew Ridge, J., Patel, U. A., Burtness, B. A. & Forastiere, A. A., Oct 1 2014, In : Clinical Cancer Research. 20, 19, p. 5041-5051 11 p.

Research output: Contribution to journalArticle

26 Scopus citations

Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: An analysis of Eastern Cooperative Oncology Group trials

Argiris, A., Li, S., Ghebremichael, M., Egloff, A. M., Wang, L., Forastiere, A. A., Burtness, B. & Mehra, R., Jul 2014, In : Annals of Oncology. 25, 7, p. 1410-1416 7 p., mdu167.

Research output: Contribution to journalArticle

55 Scopus citations
2013

A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer

Ramalingam, S. S., Kotsakis, A., Tarhini, A. A., Heron, D. E., Smith, R., Friedland, D., Petro, D. P., Raez, L. E., Brahmer, J. R., Greenberger, J. S., Dacic, S., Hershberger, P., Landreneau, R. J., Luketich, J. D., Belani, C. P. & Argiris, A., Sep 2013, In : Lung Cancer. 81, 3, p. 416-421 6 p.

Research output: Contribution to journalArticle

15 Scopus citations

Cetuximab and bevacizumab: Preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck

Argiris, A., Kotsakis, A. P., Hoang, T., Worden, F. P., Savvides, P., Gibson, M. K., Gyanchandani, R., Blumenschein, G. R., Chen, H. X., Grandi, J. R., Harari, P. M., Kies, M. S. & Kim, S., Jan 1 2013, In : Annals of Oncology. 24, 1, p. 220-225 6 p., mds245.

Research output: Contribution to journalArticle

94 Scopus citations
25 Scopus citations

Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: An eastern cooperative oncology group trial

Argiris, A., Ghebremichael, M., Gilbert, J., Lee, J. W., Sachidanandam, K., Kolesar, J. M., Burtness, B. & Forastiere, A. A., Apr 10 2013, In : Journal of Clinical Oncology. 31, 11, p. 1405-1414 10 p.

Research output: Contribution to journalArticle

128 Scopus citations

Phase I trial of carboplatin and etoposide in combination with panobinostat in patients with lung cancer

Tarhini, A. A., Zahoor, H., Mclaughlin, B., Gooding, W. E., Schmitz, J. C., Siegfried, J. M., Socinski, M. A. & Argiris, A., Oct 1 2013, In : Anticancer Research. 33, 10, p. 4475-4482 8 p.

Research output: Contribution to journalArticle

19 Scopus citations
2012

A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: A California cancer consortium trial

Gitlitz, B. J., Tsao-Wei, D. D., Groshen, S., Davies, A., Koczywas, M., Belani, C. P., Argiris, A., Ramalingam, S., Vokes, E. E., Edelman, M., Hoffman, P., Ballas, M. S., Liu, S. V. & Gandara, D. R., Mar 2012, In : Journal of Thoracic Oncology. 7, 3, p. 574-578 5 p.

Research output: Contribution to journalArticle

27 Scopus citations

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples

Kotsakis, A., Harasymczuk, M., Schilling, B., Georgoulias, V., Argiris, A. & Whiteside, T. L., Jul 31 2012, In : Journal of Immunological Methods. 381, 1-2, p. 14-22 9 p.

Research output: Contribution to journalArticle

108 Scopus citations

Phase i and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies

Argiris, A., Feinstein, T. M., Wang, L., Yang, T., Agrawal, S., Appleman, L. J., Stoller, R. G., Grandis, J. R. & Egloff, A. M., Aug 1 2012, In : Investigational New Drugs. 30, 4, p. 1575-1584 10 p.

Research output: Contribution to journalArticle

12 Scopus citations

Race and health disparities in patient refusal of surgery for early-stage non-small cell lung cancer: A SEER cohort study

Mehta, R. S., Lenzner, D. & Argiris, A., Mar 2012, In : Annals of Surgical Oncology. 19, 3, p. 722-727 6 p.

Research output: Contribution to journalArticle

26 Scopus citations

Serum biomarker modulation following molecular targeting of epidermal growth factor and cyclooxygenase pathways: A pilot randomized trial in head and neck cancer

Moskowitz, H. S., Gooding, W. E., Thomas, S. M., Freilino, M. L., Gross, N., Argiris, A., Grandis, J. R. & Ferris, R. L., Nov 1 2012, In : Oral Oncology. 48, 11, p. 1136-1145 10 p.

Research output: Contribution to journalArticle

9 Scopus citations

Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma

Wheeler, S., Siwak, D. R., Chai, R., LaValle, C., Seethala, R. R., Wang, L., Cieply, K., Sherer, C., Joy, C., Mills, G. B., Argiris, A., Siegfried, J. M., Grandis, J. R. & Egloff, A. M., Apr 15 2012, In : Clinical Cancer Research. 18, 8, p. 2278-2289 12 p.

Research output: Contribution to journalArticle

60 Scopus citations
2011

A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: A trial of the Eastern Cooperative Oncology Group (E1303)

Argiris, A., Ghebremichael, M., Burtness, B., Axelrod, R. S., Deconti, R. C. & Forastiere, A. A., Aug 1 2011, In : Cancer. 117, 15, p. 3374-3382 9 p.

Research output: Contribution to journalArticle

40 Scopus citations

A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer

Baggstrom, M. Q., Qi, Y., Koczywas, M., Argiris, A., Johnson, E. A., Millward, M. J., Murphy, S. C., Erlichman, C., Rudin, C. M. & Govindan, R., Oct 1 2011, In : Journal of Thoracic Oncology. 6, 10, p. 1757-1760 4 p.

Research output: Contribution to journalArticle

102 Scopus citations

A phase i study of concurrent chemotherapy (paclitaxel and carboplatin) and thoracic radiotherapy with swallowed manganese superoxide dismutase plasmid liposome protection in patients with locally advanced stage III non-small-cell lung cancer

Tarhini, A. A., Belani, C. P., Luketich, J. D., Argiris, A., Ramalingam, S. S., Gooding, W., Pennathur, A., Petro, D., Kane, K., Liggitt, D., Championsmith, T., Zhang, X., Epperly, M. W. & Greenberger, J. S., Mar 1 2011, In : Human Gene Therapy. 22, 3, p. 336-342 7 p.

Research output: Contribution to journalArticle

38 Scopus citations

Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer

Argiris, A., Duffy, A. G., Kummar, S., Simone, N. L., Arai, Y., Kim, S. W., Rudy, S. F., Kannabiran, V. R., Yang, X., Jang, M., Chen, Z., Suksta, N., Cooley-Zgela, T., Ramanand, S. G., Ahsan, A., Nyati, M. K., Wright, J. J. & Van Waes, C., Sep 1 2011, In : Clinical Cancer Research. 17, 17, p. 5755-5764 10 p.

Research output: Contribution to journalArticle

42 Scopus citations

Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer

Argiris, A., Karamouzis, M. V., Gooding, W. E., Branstetter, B. F., Zhong, S., Raez, L. E., Savvides, P. & Romkes, M., Mar 20 2011, In : Journal of Clinical Oncology. 29, 9, p. 1140-1145 6 p.

Research output: Contribution to journalArticle

80 Scopus citations

Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer

Argiris, A., Karamouzis, M. V., Smith, R., Kotsakis, A., Gibson, M. K., Lai, S. Y., Kim, S., Branstetter, B. F., Shuai, Y., Romkes, M., Wang, L., Grandis, J. R., Ferris, R. L., Johnson, J. T. & Heron, D. E., Nov 2011, In : Annals of Oncology. 22, 11, p. 2482-2488 7 p.

Research output: Contribution to journalArticle

12 Scopus citations

Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy

Feinstein, T. M., Lai, S. Y., Lenzner, D., Gooding, W., Ferris, R. L., Grandis, J. R., Myers, E. N., Johnson, J. T., Heron, D. E. & Argiris, A., Mar 2011, In : Head and Neck. 33, 3, p. 318-323 6 p.

Research output: Contribution to journalArticle

27 Scopus citations

Randomized phase II trial of concurrent versus sequential bortezomib plus docetaxel in advanced non-small-cell lung cancer: A california cancer consortium trial

Lara, P. N., Longmate, J., Reckamp, K., Gitlitz, B., Argiris, A., Ramalingam, S., Belani, C. P., Mack, P. C., Lau, D. H. M., Koczywas, M., Wright, J. J., Shepherd, F. A., Leighl, N. & Gandara, D. R., Jan 1 2011, In : Clinical Lung Cancer. 12, 1, p. 33-37 5 p.

Research output: Contribution to journalArticle

17 Scopus citations

Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer

Argiris, A., Lee, S. C., Feinstein, T., Thomas, S., Branstetter IV, B. F., Seethala, R., Wang, L., Gooding, W., Grandis, J. R. & Ferris, R. L., Oct 2011, In : Oral Oncology. 47, 10, p. 961-966 6 p.

Research output: Contribution to journalArticle

33 Scopus citations

Targeting GPCR-mediated p70S6K activity may improve head and neck cancer response to cetuximab

Bhola, N. E., Thomas, S. M., Freilino, M., Joyce, S., Sahu, A., Maxwell, J., Argiris, A., Seethala, R. & Grandis, J. R., Aug 1 2011, In : Clinical Cancer Research. 17, 15, p. 4996-5004 9 p.

Research output: Contribution to journalArticle

23 Scopus citations